Abstract
Unlike many other states across America that struggled to get enough diagnostic tests for coronavirus 2019 disease (COVID-19) this past spring, New Mexico was able to not only meet the demand for testing symptomatic patients, but was able to begin expanding its screening to asymptomatic individuals. How did this largely rural and relatively low-income state-among the bottom five states in population density [1] and median income per capita [2] -stay on top of testing when larger and wealthier states fell behind? The answer lies in both centralization and diversification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
